Prognostic significance of KRAS and BRAF mutations in Japanese patients with colorectal cancer

被引：0
|
作者：
Oki, Eiji [1 ]
Nakanishi, Ryota [1 ]
Ando, Koji [1 ]
Saeki, Hiroshi [1 ]
Ohga, Takefumi [1 ]
Kakeji, Yoshihiro [1 ]
Tsujitani, Shunichi [1 ]
Kohnoe, Shunji [1 ]
Maehara, Yoshihiko [1 ]
机构：
[1] Kyushu Univ, Dept Surg & Sci, Fukuoka 812, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14033
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Clinicopathological Features and Prognostic Value of KRAS/NRAS/BRAF Mutations in Colorectal Cancer Patients of Central China
    Chang, Xiao-na
    Shang, Fu-mei
    Jiang, Hong-yu
    Chen, Chen
    Zhao, Zhe-yan
    Deng, Sheng-he
    Fan, Jun
    Dong, Xiao-chuan
    Yang, Ming
    Li, Yan
    Cai, Kai-lin
    Liu, Li
    Liu, Hong-li
    Nie, Xiu
    CURRENT MEDICAL SCIENCE, 2021, 41 (01) : 118 - 126
  • [22] Distribution of KRAS and BRAF mutations in Moroccan patients with advanced colorectal cancer
    Marchoudi, N.
    Amrani Hassani Joutei, H.
    Jouali, F.
    Fekkak, J.
    Rhaissi, H.
    PATHOLOGIE BIOLOGIE, 2013, 61 (06): : 273 - 276
  • [23] KRAS and BRAF mutations in colorectal cancer patients in northwest of Iran.
    Dolatkhah, Roya
    Dastgiri, Saeed
    Somi, Mohammad Hossein
    Bonyadi, Morteza Jabbarpour
    Kermani, Iraj Asvadi
    Farassati, Faris
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [24] Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer
    Vlad Popovici
    Eva Budinska
    Fred T Bosman
    Sabine Tejpar
    Arnaud D Roth
    Mauro Delorenzi
    BMC Cancer, 13
  • [25] CLINICAL SIGNIFICANCE OF BRAF AND KRAS MUTATIONS IN PROSTATE CANCER
    Choi, S.
    Chung, J. M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 240 - 240
  • [26] Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer
    Popovici, Vlad
    Budinska, Eva
    Bosman, Fred T.
    Tejpar, Sabine
    Roth, Arnaud D.
    Delorenzi, Mauro
    BMC CANCER, 2013, 13
  • [27] Prognostic impact of BRAF and KRAS mutations according to the consensus molecular subtypes of colorectal cancer
    Smeby, J.
    Sveen, A.
    Bergsland, C. H.
    Bruun, J.
    Merok, M.
    Danielsen, S. A.
    Hektoen, M.
    Eknaes, M.
    Eilertsen, I. A.
    Guren, M. Gronlie
    Nesbakken, A.
    Lothe, R. A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [28] KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma
    Jonas Cicenas
    Linas Tamosaitis
    Kotryna Kvederaviciute
    Ricardas Tarvydas
    Gintare Staniute
    Karthik Kalyan
    Edita Meskinyte-Kausiliene
    Vaidotas Stankevicius
    Mindaugas Valius
    Medical Oncology, 2017, 34
  • [29] KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma
    Cicenas, Jonas
    Tamosaitis, Linas
    Kvederaviciute, Kotryna
    Tarvydas, Ricardas
    Staniute, Gintare
    Kalyan, Karthik
    Meskinyte-Kausiliene, Edita
    Stankevicius, Vaidotas
    Valius, Mindaugas
    MEDICAL ONCOLOGY, 2017, 34 (02)
  • [30] Frequency of KRAS, BRAF, and NRAS Mutations in Colorectal Cancer
    Vaughn, Cecily P.
    ZoBell, Scott D.
    Furtado, Larissa V.
    Baker, Christine L.
    Samowitz, Wade S.
    GENES CHROMOSOMES & CANCER, 2011, 50 (05): : 307 - 312
12345